MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2022 International Congress

    Basal forebrain contribution to cognitive deficits during medication “off” state in Parkinson’s disease

    D. Lench, T. Turner, E. Woolbright, F. Rodriguez-Porcel, G. Revuelta (Charleston, USA)

    Objective: We sought to determine whether structural integrity of cholinergic Basal Forebrain (BF) was associated with subjective cognitive deficits experienced during medication “off” time Parkinson’s…
  • 2022 International Congress

    Frequency of non-motor symptoms in GBA-PD may differ in carriers of mild vs. severe pathogenic variants

    T. Usnich, N. Brüggemann, M. Olmedillas, N. Schell, I. Csoti, S. Ertan, D. Gruber, S. Zittel, E. Sammler, S. Isaacson, A. Kühn, D. Pedrosa, K. Reetz, A. Sah, M. Kasten, P. Bauer, C. Klein (Lübeck, Germany)

    Objective: Parkinson's disease (PD) patients with pathogenic variants in the GBA (glucocerebrosidase) gene (GBA-PD) were reported to exhibit a younger age at onset, faster progression…
  • 2022 International Congress

    Characterization of nociplastic pains in Parkinson’s disease (PD) with the PD pain classification system (PD-PCS)

    V. Mylius, S. Lloret, N. Fisch, R. Gonzenbach, G. Kägi, J. Möller, F. Brugger, D. de Andrade (Valens, Switzerland)

    Objective: To describe the new category of nociplastic pain (NP). We defined Parkinson's disease (PD)-related pains and allocated them to a mechanistic category by using the…
  • 2022 International Congress

    Social cognition in Parkinson’s disease

    G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)

    Objective: Objective: To assess deficits in social cognition among patients with Parkinson’s Disease (PD) Background: Background: Social cognition is the study of how people make…
  • 2022 International Congress

    Functional Rating Scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington’s disease: The importance of the patient voice in scale development

    R. Fuller, P. Feigenbaum, N. Lapelle, S. Sathe, C. Fitzer-Attas, M. Guttman, C. Goetz, S. Luo, B. Tilley, P. Dalal, C. Sampaio, G. Stebbins (Princeton, USA)

    Objective: Use focus groups, a Delphi panel, and multiple iterations of cognitive pretesting to develop a patient-reported outcome (PRO) measure of function in Huntington’s disease…
  • 2022 International Congress

    Factors associated with progression of Parkinson’s disease and deterioration in quality of life: Results of J-FIRST, a 1-year observational study

    K. Kashihara, S. Chiu, Y. Tsuboi, N. Hattori, M. Nomoto, H. Watanabe, T. Maeda, H. Saiki, Y. Shimo, T. Yamaguchi (Okayama, Japan)

    Objective: To investigate whether individual non-motor symptoms (NMSs) are associated with overall NMS or quality of life (QOL) in Parkinson's disease (PD). Background: Worsening motor…
  • 2022 International Congress

    Neuropsychological evaluation of cerebellar cognitive function in a series of patients with genetically confirmed CANVAS.

    I. Albajar, J. Equiza, A. Lopez-de-Munain, M. Barandiaran, A. Pujol Onofre, J. Ruiz, M. Maneiro, E. Mondragon, A. Vargas, V. Velez, M. Ruiz Sales, E. Verdura Peralta, P. Iruzubieta (San Sebastian, Spain)

    Objective: We aim to present the cerebellar cognitive affective evaluation and phenotypic description of a series of genetically confirmed CANVAS. Background: Cerebellar ataxia, neuropathy and…
  • 2022 International Congress

    The non-motor features of essential tremor with midline distribution

    A. Rekik, I. Kacem, S. Mrabet, Y. Abida, A. Gharbi, A. Souissi, A. Gargouri, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: To investigate the non-motor signs among essential tremor (ET) patients presenting with midline tremor (Mid-ET). Background: Midline essential tremor represents a distinctive group of…
  • 2022 International Congress

    Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey

    J. Janssen Daalen, J. Hubbers, M. Sharifi Bonab, S. Mathur, D. Thijssen, B. Bloem, M. Meinders (Nijmegen, Netherlands)

    Objective: As insight in the drivers of varying symptom severity might help manage symptoms, this study investigates the association between symptom severity and contextual factors…
  • 2022 International Congress

    Impact on non-motor symptoms, cognition, and QoL after 1-year of DBS for Parkinson’s Disease: An interim report from the ADROIT NAPA sub-study

    M. Poetter-Nerger, S. Groppa, O. Adam, A. Schnitzler, M. Navas Garcia, B. Cheeran, L. Himes, M. Frassica, A. Gharabaghi (Hamburg, Germany)

    Objective: To present the impact on cognition, quality of life, and non-motor symptoms after 1-year of DBS for Parkinson’s Disease through the ADROIT post-market study.…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley